2024-09-03

INSIDE INFORMATION - THE H SHARE FULL CIRCULATION LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE

2024-08-26

ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024

2024-08-22

VOLUNTARY ANNOUNCEMENT - UPFRONT PAYMENT RECEIVED UNDER THE LICENSE AND COLLABORATION AGREEMENT WITH SYNBIOTX FOR IMM2510 AND IMM27M

2024-08-14

DATE OF BOARD MEETING

2024-08-06

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024

2024-08-01

INSIDE INFORMATION - LICENSE AND COLLABORATION AGREEMENT WITH SYNBIOTX FOR IMM2510 AND IMM27M

2024-07-30

(1) RESIGNATION OF SUPERVISOR; AND (2) ELECTION OF EMPLOYEE REPRESENTATIVE SUPERVISOR

2024-07-24

VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE IB CLINICAL TRIAL OF IMM2510 IN COMBINATION WITH IMM27M

2024-07-05

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024

2024-07-03

VOLUNTARY ANNOUNCEMENT - UPDATES ON THE CLINICAL TRIAL OF IMM01 (TIMDARPACEPT) IN COMBINATION WITH TISLELIZUMAB

2024-06-21

VOLUNTARY ANNOUNCEMENT - UPDATES ON THE CLINICAL TRIAL OF IMC-002

2024-06-05

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2024

2024-06-03

VOLUNTARY ANNOUNCEMENT - APPROVAL BY NMPA FOR A PHASE III CLINICAL TRIAL OF IMM01 (TIMDARPACEPT) IN COMBINATION WITH AZACITIDINE FOR THE FIRST-LINE TREATMENT OF CMML

2024-05-29

INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION OF CERTAIN UNLISTED SHARES OF THE COMPANY

2024-05-28

List of Directors and their Role and Function

2024-05-28

I. POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 28, 2024; II. APPOINTMENT OF DIRECTOR

2024-05-17

VOLUNTARY ANNOUNCEMENT - APPROVAL BY NMPA FOR A RANDOMIZED, DOUBLEBLIND, CONTROLLED PHASE III CLINICAL TRIAL OF IMM01 (TIMDARPACEPT) IN COMBINATION WITH AZACITIDINE

2024-05-07

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024

2024-04-29

Proxy Form for the Annual General Meeting to be held on May 28, 2024

2024-04-29

NOTICE OF THE ANNUAL GENERAL MEETING